Lavinia Bianco
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Lavinia Bianco has a total of 21 co-authors. Here are the top co-authors by number of shared publications:
- Alessia Nardangeli
UOC Radioterapia Oncologica, Dipartimento Di Diagnostica Per Immagini, Radioterapia Oncologica ed Ematologia, Fondazione Policlinico Universitario “A. Gemelli” IRCCS, Roma, Italy
1 shared publication Andrea Ruggieri
Department of Oncology, Radiation Oncology, School of Medicine, Azienda Ospedaliera Ordine Mauriziano Umberto I, University of Turin, Turin, Italy
1 shared publication- Anna Rita Alitto
UOC di Radioterapia Oncologica, Dipartimento Diagnostica per Immagini, Radioterapia Oncologica ed Ematologia, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy
1 shared publication Annalisa Rossi
Department of Oncology, Radiation Oncology, School of Medicine, Azienda Ospedaliera Ordine Mauriziano Umberto I, University of Turin, Turin, Italy
1 shared publicationChiara De Colle
Department of Oncology, Radiation Oncology, School of Medicine, Azienda Ospedaliera Ordine Mauriziano Umberto I, University of Turin, Turin, Italy
1 shared publicationClaudia Airaldi
Department of Oncology, Radiation Oncology, School of Medicine, Azienda Ospedaliera Ordine Mauriziano Umberto I, University of Turin, Turin, Italy
1 shared publication
Latest Publications
- 4 October 2019
- Published by Springer Nature in Strahlentherapie und Onkologie
- Vol. 196 (1) , 1-14
Role of upper abdominal reirradiation for gastrointestinal malignancies: a systematic review of cumulative dose, toxicity, and outcomes on behalf of the Re-Irradiation Working Group of the Italian Association of Radiotherapy and Clinical Oncology (AIRO)
Abdominal recurrences of gastrointestinal malignancies are common. Evidence in clinical studies has shown that re-irradiation (Re-I) is tolerable and efficient in different tumor locations. In contrast, little clinical data are available on normal long-term Re‑I tolerance doses. A systematic review of upper abdominal Re‑I was performed with the aim of exploring the cumulative dose, toxicity, and outcomes.
- 4 October 2019
- Published by Springer Nature in Strahlentherapie und Onkologie
- Vol. 196 (1) , 1-14
Role of upper abdominal reirradiation for gastrointestinal malignancies: a systematic review of cumulative dose, toxicity, and outcomes on behalf of the Re-Irradiation Working Group of the Italian Association of Radiotherapy and Clinical Oncology (AIRO)
Abdominal recurrences of gastrointestinal malignancies are common. Evidence in clinical studies has shown that re-irradiation (Re-I) is tolerable and efficient in different tumor locations. In contrast, little clinical data are available on normal long-term Re‑I tolerance doses. A systematic review of upper abdominal Re‑I was performed with the aim of exploring the cumulative dose, toxicity, and outcomes.
- 3 February 2018
- Published by Springer Nature in La radiologia medica
- Vol. 123 (6) , 463-468
Heterotopic ossifications: role of radiotherapy as prophylactic treatment
Heterotopic ossification (HO) is abnormal formation of lamellar bone in soft tissue; the most frequent causes are total hip arthroplasty and trauma. Severe cases can lead to ankilosis with important impact on quality of life. Surgery is the elective treatment, but, especially in high-risk patients, it is important to prevent the re-formation of HO and, in these cases, radiotherapy (RT) can play an important role.
- 3 February 2018
- Published by Springer Nature in La radiologia medica
- Vol. 123 (6) , 463-468
Heterotopic ossifications: role of radiotherapy as prophylactic treatment
Heterotopic ossification (HO) is abnormal formation of lamellar bone in soft tissue; the most frequent causes are total hip arthroplasty and trauma. Severe cases can lead to ankilosis with important impact on quality of life. Surgery is the elective treatment, but, especially in high-risk patients, it is important to prevent the re-formation of HO and, in these cases, radiotherapy (RT) can play an important role.